Abstract 063: Evaluation of a Combination Therapy of Bone Marrow-Derived Stem Cells and Serelaxin Against Established Renal Fibrosis in Normotensive and Hypertensive Models of Disease

Fibrosis significantly impairs the viability and therapeutic efficacy of stem cell-based therapies. To overcome this, we demonstrated that the anti-fibrotic drug, serelaxin (recombinant human relax...